The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis.
Ehsan Amini-SalehiSoheil HassanipourMohammad-Hossein KeivanlouMilad ShahdkarMahdi Orang GoorabzarmakhiAzin VakilpourFarahnaz JoukarMohammad HashemiNazila SattariMohammadreza JavidFariborz Mansour-GhanaeiPublished in: Nutrition reviews (2023)
PROSPERO registration no. CRD42022346998.